Scott J. Sherman
Neurology
2800 East Ajo Way
Tucson, AZ 85713
Tucson, AZ 85713
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Differential effects of statins on the anti-dyskinetic activity of sub-anesthetic ketamine.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024
Differential effects of statins on the anti-dyskinetic activity of sub-anesthetic ketamine.
Journal: Neuroscience letters
Published: October 21, 2024
Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model.
Journal: Neuropharmacology
Published: March 26, 2024
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
Journal: bioRxiv : the preprint server for biology
Published: August 14, 2023
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
Journal: Brain research
Published: August 03, 2023
Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome.
Journal: Sensors (Basel, Switzerland)
Published: May 06, 2022
Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT.
Journal: Tomography (Ann Arbor, Mich.)
Published: October 12, 2021
Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment.
Journal: Neuroscience letters
Published: August 23, 2021
The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia.
Journal: International journal of molecular sciences
Published: November 20, 2020
Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.
Journal: Experimental neurology
Published: October 10, 2020
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.
Journal: BMC research notes
Published: January 21, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.
Journal: Experimental neurology
Published: January 17, 2020
Last Updated: 09/26/2026